Tag archive for ‘cancer immunotherapy’
Gali Raz On Tuesday, January 12th, 2021

Biond Biologics and Sanofi Enter into Global Licensing Agreement Worth $1 Billion

Tehila Ben-Moshe co-founder and CEO Israeli biopharmaceutical company Biond Biologics which developing novel immunotherapies for cancer has entered into an exclusive worldwide license agreement with Sanofi, More...

John Hopkins University and Compugen team on immune checkpoints

– The collaboration will focus on immune checkpoint candidates discovered by Compugen for the potential treatment of cancer. –   Compugen Ltd. (Nasdaq: CGEN; TASE: CGEN) today announced the More...

Ilan Shavit On Monday, August 5th, 2013

Compugen drug discovery company signs $500 million agreement with Bayer

– Compugen and Bayer will collaborate on development and commercialization of antibody-based cancer immunotherapies. Anat Cohen-Dayag, Ph.D., President and CEO of Compugen – /By Ilan Shavit More...

Wordpress site Developed by Fixing WordPress Problems